Promise Bio is using broad epiproteomics and AI to advance precision medicine for chronic diseases. Our platform provides comprehensive post-translational modification (PTM) profiling enhanced with clinical and functional context, delivering insights for precise, data-driven decisions. We partner with leading research organizations and pharmaceutical companies to discover novel biomarkers, treatment selection tools, and drug targets.